IFP Advisors
RCEL icon

IFP Advisors’s Avita Medical RCEL Stock Holding History

IFP Advisors’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.51K Sell
129
-280
-68% -$2.22K ﹤0.01% 4346
2026
Q2 		$1.69K Buy
409
+377
+1,178% +$1.63K ﹤0.01% 4308
2026
Q1 		$118 Buy
32
+2
+7% +$8 ﹤0.01% 4710
2025
Q4 		$104 Sell
30
-3
-9% -$12 ﹤0.01% 4583
2025
Q3 		$169 Buy
33
+31
+1,550% +$162 ﹤0.01% 4427
2025
Q2 		$11 Sell
2
-2
-50% -$15 ﹤0.01% 4871
2025
Q1 		$33 Hold
4
– – ﹤0.01% 4098
2024
Q4 		$51 Buy
+4
New +$47 ﹤0.01% 4253
2023
Q3 		– Sell
-183
Closed -$3.11K – 3504
2023
Q2 		$3.11K Buy
+183
New +$2.68K ﹤0.01% 2717
2023
Q1 		– Sell
-2,475
Closed -$74K – 4216
2022
Q4 		$74K Sell
2,475
-255
-9% -$1.53K ﹤0.01% 1956
2022
Q3 		$81K Hold
2,730
– – ﹤0.01% 2005
2022
Q2 		$81K Hold
2,730
– – ﹤0.01% 1827
2022
Q1 		$81K Buy
+2,730
New +$25.2K ﹤0.01% 1827

Other funds holding RCEL

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
Thompson Davis & Co
Thompson Davis & Co Richmond, Virginia $149M AUM 10.53% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Abel Hall LLC
Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return
Harpswell Capital Advisors
Harpswell Capital Advisors Yarmouth, Maine $152M AUM 8.39% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

IFP Advisors's RCEL Position: Q3 2026 in Review

IFP Advisors reduced its Avita Medical (RCEL) stake by 68% in Q3 2026, selling an estimated $2.22K and leaving 129 shares worth $1.51K. The position accounts for ﹤0.01% of the portfolio, ranked #4346.

IFP Advisors first reported a position in RCEL in Q1 2022 and has held it in 13 quarters since. The position peaked at $81K in Q3 2022. 21 funds tracked by Wall St. Rank hold RCEL as of Q3 2026.

  • IFP Advisors held 129 shares of Avita Medical worth $1.51K as of Q3 2026.
  • IFP Advisors sold 280 Avita Medical shares in Q3 2026, an estimated $2.22K.
  • Avita Medical made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #4346 holding.
  • IFP Advisors first reported a position in Avita Medical in Q1 2022 and has held it in 13 quarters since.
  • IFP Advisors's Avita Medical position peaked at $81K in Q3 2022.
  • 21 funds tracked by Wall St. Rank held Avita Medical as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.